Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Is a universal flu vaccine on the horizon?

Oxford University spin-out company Vaccitech is trialling what it hopes will be a more effective, universal flu vaccine. The company recently raised £20m from investors including Google parent firm Alphabet, and has a Phase II study underway to test the efficacy of its vaccine. Chris Lo talks to co-founder Professor Sarah Gilbert about the science behind the vaccine, and the potentially revolutionary benefits of inducing T-cells.


Go Top